Legislation to Curtail Third-Party Litigation Funding Advances – IA Magazine

Third-party litigation funding used to be the sort of legal topic that lived in the attic of public policy: important, dusty, and mostly ignored unless you worked in a courthouse, a hedge fund, or a conference room with too much coffee and too many redlines. Not anymore. In Washington and in several state capitals, lawmakers are moving to pull litigation finance into the sunlight, and they are doing it with more urgency than ever.

At its core, third-party litigation funding, often shortened to TPLF, allows an outside financier to put money into a lawsuit in exchange for a share of any eventual recovery. Supporters say that model can help plaintiffs and smaller businesses stand up to deep-pocketed defendants. Critics say it can distort litigation, obscure who is really calling the shots, and in some cases open the door to foreign influence in American courts. That disagreement is no longer a niche debate. It is becoming a legislative agenda.

The latest wave of proposals shows that lawmakers are not simply asking whether litigation funding exists. They are asking who should know about it, who should regulate it, and how far the law should go to stop funders from steering cases behind the scenes. For insurers, defense counsel, risk managers, brokers, and anyone watching social inflation with one eye and claims severity with the other, this shift matters a great deal.

Why the legislative push is gaining speed

The momentum behind litigation funding reform comes from a simple complaint: too much of this market has operated out of public view. In many cases, an opposing party may suspect a lawsuit is backed by outside capital without knowing who the funder is, what rights the funder has, whether the funder can influence settlement decisions, or whether a foreign entity is financing the case. To critics, that is not a minor paperwork problem. It is a structural transparency problem.

That concern lands especially hard in large commercial disputes, mass torts, and class actions, where the dollars are huge, the discovery can be sensitive, and the pressure to settle can be intense. If an undisclosed funder stands to make a significant return, skeptics argue, the litigation may stop being just a dispute between plaintiff and defendant and start looking a little more like an investment product wearing a lawsuit costume.

Foreign money has turned that policy concern into something even more politically potent. Lawmakers in Congress and several states increasingly frame the issue not only as a consumer protection or civil procedure matter, but also as a national security question. The argument is straightforward: if foreign governments, sovereign wealth funds, or foreign-linked entities can quietly bankroll litigation in the United States, they may gain leverage, access, or intelligence in ways the legal system was never designed to encourage.

What the new legislation is trying to do

Federal lawmakers are splitting the issue into two buckets

The recent federal proposals suggest that Congress is experimenting with two related but distinct approaches. The first is broad transparency. This version would require parties in civil litigation to disclose when outside financiers have a contingent financial interest in the outcome. Supporters say that kind of disclosure would help courts understand who is really involved in a case and whether hidden financial interests are shaping strategy.

The second approach is narrower but sharper: target foreign influence specifically. That is the theory behind measures aimed at foreign persons, foreign states, and sovereign wealth funds. Instead of treating all litigation funding the same, these proposals focus on the types of funding relationships lawmakers see as most likely to create national security, trade secret, or courtroom-integrity concerns.

That split matters because it reveals where the politics are moving. A sweeping disclosure rule for every civil case can draw resistance from across the ideological map. A foreign-funding crackdown, by contrast, is easier to frame as a court-integrity measure rather than a frontal assault on litigation finance itself. In policy terms, it is the difference between saying, “Tell us everything,” and saying, “At minimum, tell us when foreign money is in the room.”

States are building a practical playbook

While Congress debates, the states are doing what states often do best: writing practical rules. In 2025, several jurisdictions moved ahead with legislation or procedural reforms that focus on disclosure, funder conduct, and foreign participation. The emerging state model is not especially mysterious. It tends to include some combination of disclosure requirements, registration or reporting obligations, restrictions on funder control, and limits on access to confidential or protected information.

Kansas offers a useful example of how granular these laws are becoming. Its 2025 law requires parties to provide litigation funding agreements to the court for in camera review and to disclose, in sworn form, the identity of contracting parties, any funder control or approval rights, confidentiality access, relationships that could raise conflicts, and whether funding is tied to a foreign person from a country of concern. That is not a symbolic nod to transparency. That is a checklist with teeth.

Colorado took a related but distinct route with a law aimed at foreign third-party litigation financing. Its framework requires disclosure to the attorney general, bars funders from directing counsel or steering settlement, and limits the sharing of proprietary or national-security-sensitive information. Georgia’s 2025 tort reform package similarly leaned into transparency, anti-foreign-influence language, and consumer protection, while Oklahoma’s new law requires disclosure of commercial funding agreements and any foreign government involvement. Different states, same basic message: if you want to fund litigation, lawmakers increasingly expect you to do it in daylight.

Why insurers and reform advocates are cheering

From an insurance and risk perspective, the appeal of reform is not hard to understand. Opponents of opaque litigation funding argue that hidden capital can extend the life of lawsuits, complicate settlement, and push claim values upward. In insurance circles, those dynamics are often discussed under the broad and much-debated umbrella of social inflation. The theory is that outside funding can add heat to already expensive litigation by encouraging longer fights and higher settlement demands.

Reform advocates also argue that disclosure can reduce gamesmanship. If a court knows a funder exists, and if the opposing side knows whether that funder has veto rights, approval rights, or access to confidential materials, judges can manage cases more intelligently. In other words, transparency is not just about curiosity. It is about court administration, conflict detection, and making sure that litigation decisions remain tethered to the interests of the actual litigants.

There is also a consumer-protection angle. Many reform supporters insist that plaintiffs should not sign funding agreements without clear disclosures about pricing, repayment, control, and the practical effect on a future recovery. That concern is especially strong where commercial TPLF and consumer legal funding get lumped together in public debate. Lawmakers are increasingly trying to separate the concepts, but the shared concern remains the same: vulnerable litigants should not discover too late that their settlement has many hungry hands reaching into it.

Why funders and access-to-justice advocates are pushing back

Of course, the other side is not exactly whispering. Litigation funders and their allies argue that the reform movement often overstates the risks while understating the benefits. In their view, funding can level the playing field by giving individuals and small businesses the resources needed to pursue valid claims against better-funded adversaries. They say that without outside capital, some meritorious claims would be settled cheaply, abandoned early, or never filed at all.

They also argue that some disclosure proposals are drafted too broadly. A bill that forces public identification of every entity with a contingent interest in litigation proceeds may sweep in more than hedge funds and commercial funders. Critics of the broadest versions warn that those laws could expose sensitive strategy, chill lawful investment, complicate donor privacy questions, and hand defendants a tactical advantage before the merits are ever tested.

This is why the debate has become unusually interesting. It is not a clean battle between the left and the right, or between business and plaintiffs. Some conservatives favor disclosure in the name of transparency and national sovereignty, while others object that the same rules could chill advocacy litigation or expose donor networks. Some plaintiff-side voices defend funding as access to justice, while others are open to guardrails so long as those guardrails do not become a padlock.

The practical impact on the insurance industry

For independent agents, carriers, claims professionals, and commercial insureds, the legislative trend matters for several reasons. First, more disclosure can improve litigation forecasting. If a claim is being funded by a third party with a substantial financial stake, that may affect the pace of the case, settlement posture, and expected cost curve. Knowing that earlier can sharpen reserve decisions and litigation strategy.

Second, foreign-funding restrictions may reduce some of the uncertainty surrounding highly sensitive commercial disputes. Businesses involved in trade secrets, energy, infrastructure, technology, and other strategically important sectors have a particular interest in how funding reforms handle confidential information. A rule that limits funder access to protected discovery is not just a procedural tweak. In some cases, it can be a major business safeguard.

Third, these laws may slowly reshape claims behavior. If funders face tighter disclosure rules, restrictions on control, or registration requirements, the economics of certain cases may change. Some cases may become less attractive to outside capital. Others may proceed with more careful contract drafting and more judicial scrutiny. Either way, litigation funding is becoming less of a hidden variable.

What happens next

The direction of travel is clear even if the final map is not. The United States is moving toward more regulation of third-party litigation funding, not less. The real question is what flavor that regulation takes. Congress may continue struggling to pass a sweeping federal framework, particularly when lawmakers worry about overbreadth. But narrower proposals centered on foreign funding, class actions, mass torts, and anti-control rules appear to have stronger political footing.

At the state level, expect more tailored laws. Legislatures seem increasingly interested in drafting rules that separate commercial litigation finance from consumer legal funding, while still demanding transparency, restricting funder control, and addressing foreign involvement. That is a more durable political formula because it sounds less like a war on finance and more like a rulebook for courtroom fairness.

So yes, legislation to curtail third-party litigation funding is advancing. But “curtail” may not be the perfect verb in every jurisdiction. In many places, lawmakers are not trying to ban the practice outright. They are trying to box it in, label it clearly, and keep it from pretending to be invisible. For a market built partly on staying behind the curtain, that is a very big change.

Experiences from the field: what this debate looks like in real life

If all of this still sounds abstract, consider how the issue tends to feel on the ground. A claims executive may spend months valuing a case based on the plaintiff’s injuries, the venue, the experts, and the normal range of settlement behavior, only to discover that the case is no longer being driven solely by the plaintiff’s appetite for resolution. Suddenly the litigation has another gravity source. Nobody likes surprise gravity.

Defense lawyers describe a similar experience in funded cases: settlement conversations can become harder to read. A number that once might have ended the dispute no longer lands the same way because there may be contractual return expectations sitting behind the scenes. Even when the funder has no formal right to control the case, everyone in the room knows money has a way of developing opinions. Sometimes very strong opinions.

On the plaintiff side, the experience is not always villainous or dramatic. Some businesses and claimants genuinely use funding to stay in the fight. A smaller company facing a well-financed corporate defendant may view litigation funding as the only realistic way to survive a multi-year lawsuit. Plaintiffs’ counsel may see it as a tool that prevents a stronger party from winning by attrition. That is why the policy debate has traction on both sides: there are real stories behind both the fear and the defense of funding.

Judges, meanwhile, are left to manage cases in a world where the formal caption may tell only part of the story. If courts do not know who is funding litigation, whether that funder has approval rights, or whether confidential materials may be shared beyond the parties, then judges are being asked to referee a game without a full roster. That frustration explains why disclosure has become such a recurring theme in reform proposals.

Insurance professionals often experience the issue through outcomes rather than theory. They see tougher settlement dynamics, more complicated negotiations, and litigation that sometimes seems to acquire more stamina than the underlying merits alone would predict. That does not prove every funded case is distorted. It does explain why insurers have been unusually vocal in calling for transparency and limits on control.

State lawmakers appear to be learning from those experiences. The most durable legislation does not assume every funder is a cartoon villain twirling a mustache in a boardroom. Instead, it responds to recurring practical concerns: undisclosed interests, unclear control rights, access to confidential information, predatory terms for consumers, and the possibility of foreign influence in sensitive disputes. That approach is more likely to survive because it is tied to case management and litigant protection, not just rhetoric.

The real lesson from the recent wave of reforms is that litigation funding is no longer treated as a quirky side market. It is now seen as a factor that can alter incentives across the legal system, from filing decisions to discovery fights to settlement strategy. Once lawmakers and courts start viewing a financial product as something that can reshape litigation behavior, regulation is usually not far behind. In that sense, the recent legislative advances are not surprising at all. They are what happens when a once-obscure market gets large enough, influential enough, and controversial enough that the legal system decides it would finally like to know who is sitting at the table.

Conclusion

The push to regulate third-party litigation funding has moved from policy white papers to real legislative action. Congress is still debating how broad federal rules should be, but the momentum behind foreign-funding restrictions, disclosure requirements, and anti-control provisions is unmistakable. States are not waiting around for Washington to make up its mind, and that may be the most important development of all.

For the insurance world, the lesson is simple: this is not just a legal-tech curiosity or a niche plaintiffs’ bar issue. It is part of a broader fight over litigation transparency, courtroom integrity, settlement leverage, consumer protection, and the future cost of civil justice. The age of invisible litigation funding is ending, or at least getting much harder to pull off without a flashlight pointed directly at it.